Justice Department, Drug Enforcement Administration
This is notice that the Drug Enforcement Administration will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act. The proposed rescheduling of marijuana was initially proposed in a Notice of Proposed Rulemaking published in the Federal Register on May 21, 2024.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Drug Enforcement Administration 21 CFR Part 1301 [Docket No. DEA-1362] RIN 1117-AB77 AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Notice of hearing on proposed rulemaking. SUMMARY: This is notice that the Drug Enforcement Administration will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act. The proposed rescheduling of marijuana was initially proposed in a Notice of Proposed Rulemaking published in the Federal Register on May 21, 2024. DATES: Interested persons desiring to participate in this hearing must provide written notice of desired participation as set out below, on or before September 30, 2024. The hearing will commence on December 2, 2024, at 9 a.m. ET at 700 ( printed page 70149) Army Navy Drive, Arlington, VA 22202. The hearing may be moved to a different place and may be continued from day to day or recessed to a later date without notice other than announcement thereof by the presiding officer at the hearing. 21 CFR 1316.53 . ADDRESSES: To ensure proper handling of notification, please reference “Docket No. DEA-1362” on all correspondence. Electronic notification should be sent to nprm@dea.gov . Paper notification sent via regular or express mail should be sent to Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Drug and Chemical Evaluation Se…
Other Federal Register documents from the same docket.
Citation: 89 FR 70148
